Gexval

–/10Traction

The startup develops pharmaceutical compounds targeting orphan and intractable diseases, specifically in psychiatry, neurology, and pulmonary arterial hypertension. By providing cost-effective treatment options, the company enables physicians to manage rare and incurable conditions more effectively.

Fujisawa, Japan · HQ

Biotechnology

Updated 4 months ago

Funding

Funding not disclosed

Axil CapitalNo round attributed

axilcapital.com (opens in a new tab)investor website

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Features

The startup develops pharmaceutical compounds targeting orphan and intractable diseases, specifically in psychiatry, neurology, and pulmonary arterial hypertension. By providing cost-effective treatment options, the company enables physicians to manage rare and incurable conditions more effectively.